Published in Saudi J Gastroenterol on March 04, 2011
Successful application of ankaferd blood stopper in a patient with lower gastrointestinal bleeding. Saudi J Gastroenterol (2011) 0.83
Local use of ankaferd blood clotter in emergent beating heart coronary artery bypass grafting. Open Cardiovasc Med J (2015) 0.77
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (2007) 9.44
Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res (2008) 3.47
Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc (2009) 2.59
Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis. Dig Liver Dis (2009) 2.14
Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol (2008) 1.40
Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Princ Pract (2009) 1.31
Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy (2008) 1.18
Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol (2009) 1.17
The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis (2009) 1.13
Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model. Clin Appl Thromb Hemost (2009) 1.08
Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost (2009) 1.06
A randomized trial of endoscopic cyanoacrylate injection for acute gastric variceal bleeding: 0.5 mL versus 1.0 mL. Gastrointest Endosc (2009) 0.90
Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci (2014) 2.06
Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib. Ann Pharmacother (2015) 2.01
The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature. Dig Dis Sci (2009) 1.86
Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calcium. Am J Cardiol (2006) 1.49
Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever. Rheumatol Int (2013) 1.42
Acute myocardial infarction after sildenafil citrate ingestion. Ann Pharmacother (2005) 1.42
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40
Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Princ Pract (2009) 1.31
In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost (2009) 1.27
Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis. Clin Res Hepatol Gastroenterol (2011) 1.24
Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med (2009) 1.17
The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis (2009) 1.13
Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma. Ann Hematol (2008) 1.07
Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost (2009) 1.06
Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis. Hepatogastroenterology (2012) 1.03
A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd blood stopper. Dig Liver Dis (2009) 1.01
Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Crit Rev Oncol Hematol (2011) 1.01
The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd blood stopper. Hepatogastroenterology (2010) 0.98
Successful treatment of endoscopic sphincterotomy-induced early hemorrhage with application of Ankaferd Blood Stopper. Gastrointest Endosc (2010) 0.91
Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. Platelets (2004) 0.91
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate. Hematology (2013) 0.91
Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis. Rheumatol Int (2005) 0.91
Controversies about occult hepatitis B virus infection. World J Gastroenterol (2009) 0.88
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol (2011) 0.88
Second-generation BCR-ABL kinase inhibitors in CML. N Engl J Med (2010) 0.88
Ankaferd hemostat in the management of gastrointestinal hemorrhages. World J Gastroenterol (2011) 0.88
Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis. Blood Coagul Fibrinolysis (2012) 0.88
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2010) 0.87
Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J Natl Med Assoc (2007) 0.87
Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis Rheum (2003) 0.87
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol (2012) 0.86
Ruxolitinib for myelofibrosis. N Engl J Med (2012) 0.86
Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper. Phytother Res (2011) 0.86
Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol (2005) 0.86
Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J (2010) 0.86
Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma (2006) 0.86
Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses. Clin Appl Thromb Hemost (2012) 0.85
Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis. Clin Res Hepatol Gastroenterol (2011) 0.84
Unusual extramedullary recurrences and breast relapse despite hepatic GVHD after allografting in Ph+-ALL. Hematology (2006) 0.84
Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia. Am J Hematol (2005) 0.84
Ankaferd Blood Stopper in GI bleeding: alternative for everything? Gastrointest Endosc (2011) 0.84
Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia. J Natl Med Assoc (2006) 0.83
Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Hepatogastroenterology (2010) 0.83
Isolated granulocytic sarcoma of the head and neck preceding acute myeloid leukemia. Am J Hematol (2004) 0.83
[Evaluation of treatment results among patients with acute gastrointestinal bleeding due to Dieulafoy's lesion admitted to the emergency department]. Ulus Travma Acil Cerrahi Derg (2013) 0.83
Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. J Crohns Colitis (2012) 0.83
The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment. Expert Opin Pharmacother (2013) 0.83
Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. Hematology (2002) 0.83
Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36:163-170. J Int Med Res (2008) 0.82
An alternative hemostatic method for early GI bleeding caused by anastomotic ulcer. Gastrointest Endosc (2010) 0.82
Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. Liver Int (2013) 0.81
Thrombomodulin and GFC levels in Legg-Calve-Perthes disease. Hematology (2008) 0.81
Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Indian J Gastroenterol (2010) 0.81
Controlling of upper gastrointestinal bleeding associated with severe immune thrombocytopenia via topical adjunctive application of Ankaferd blood stopper. Blood Coagul Fibrinolysis (2012) 0.81
Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever. Med Hypotheses (2006) 0.80
Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma. Onkologie (2009) 0.80
Molecular basis of colorectal cancer. N Engl J Med (2010) 0.80
Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease. Pediatr Hematol Oncol (2005) 0.80
Late autoimmune hepatitis after hepatitis C therapy. Eur J Gastroenterol Hepatol (2013) 0.80
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Transfus Apher Sci (2013) 0.80
Local umbilical cord blood renin-angiotensin system. Ann Hematol (2005) 0.80
How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems. Med Hypotheses (2004) 0.80
Vitamin D levels in patients with chronic hepatitis B. Hepatology (2014) 0.80
Effects of acute exercise on fibrinolysis and coagulation in patients with coronary artery disease. Int Heart J (2007) 0.79
Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model. Int J Biomater (2013) 0.79
Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study. Acta Haematol (2013) 0.79
Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders. J Renin Angiotensin Aldosterone Syst (2012) 0.79
Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. Autoimmun Rev (2011) 0.79
Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome. Blood Coagul Fibrinolysis (2008) 0.78
Do all hemolytic anemias that occur after mitral valve repair require surgical treatment? Clin Cardiol (2010) 0.78
Outcome of pregnancy in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: a report of two cases. Clin Res Hepatol Gastroenterol (2011) 0.78
Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome. Am J Med Sci (2008) 0.78
A comparison of Jurkat cell-reactive anti-T lymphocyte globulin and fetal anti-thymocyte globulin preparations in the treatment of aplastic anemia. Med Princ Pract (2011) 0.78
Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level. Clin Rheumatol (2004) 0.78
Thiocolchicoside-induced liver injury. Clinics (Sao Paulo) (2011) 0.78
The impact of sphincterotome design on selective cannulation of the common bile duct. J Gastroenterol Hepatol (2013) 0.78
Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Clin Res Hepatol Gastroenterol (2011) 0.77
Which is the best approach for the hemorrhagic duodenal lipoma: endoscopic resection or surgery? Am J Surg (2011) 0.77
Increased circulating soluble P-selectin in polycystic ovary syndrome. Fertil Steril (2009) 0.77
Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents. Hepatology (2010) 0.77
Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid mass. Leuk Lymphoma (2006) 0.77
Coffee intake and chronic hepatitis C. Hepatology (2009) 0.77
The diagnosis of autoimmune hepatitis in patients with adult-onset Still's disease. J Clin Apher (2010) 0.77
Membranous glomerulonephritis associated with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a very rare condition. Eur J Gastroenterol Hepatol (2010) 0.77
Next generation nanomedicine in the genesis of "Ankaferd blood stopper nanohemostat": a novel chimeric topical hemostatic agent for clinical hemorrhages. Clin Appl Thromb Hemost (2013) 0.77
Local bone marrow Renin-Angiotensin system and atherosclerosis. Cardiol Res Pract (2010) 0.77
In vivo confocal microscopic characteristics of crystalline keratopathy in patients with monoclonal gammopathy: report of two cases. Indian J Ophthalmol (2014) 0.77
Renin-angiotensin system expression in the K562 human erythroleukaemic cell line. J Renin Angiotensin Aldosterone Syst (2007) 0.77